MOGAT2 and colorectal carcinoma: Finally, CA2, CHP2, SULT1B1, MOGAT2 and C1orf115 were successfully validated with their low expression in CRC cell lines, while the only lncRNA (RP11-396O20.2) we chose failed to be verified.